| http://www.w3.org/ns/prov#value | - Peripheral edema is a common adverse event associated with the use of dasatinib.44,45 Pleural effusion, the most important and limiting toxicity during dasatinib treatment, often requires treatment discontinuation that impairs the otherwise high efficacy of the drug.44??????-47 A very recent study reported that 52 of 172 patients with chronic myeloid leukemia developed pleural effusion during trea
|
